CLGN — Collplant Biotechnologies Balance Sheet
0.000.00%
- $20.85m
- $8.94m
- $0.52m
Annual balance sheet for Collplant Biotechnologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.33 | 43.3 | 29.7 | 26.7 | 11.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.07 | 0.694 | 0.552 | 0.393 | 0.583 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 5.68 | 45.1 | 31.7 | 28 | 13.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.9 | 5.68 | 5.68 | 5.86 | 5.28 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 10.8 | 51.2 | 37.8 | 34.1 | 18.7 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.39 | 3.01 | 3.1 | 3.25 | 2.97 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.36 | 6.1 | 5.49 | 5.79 | 5.25 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 4.48 | 45.1 | 32.3 | 28.3 | 13.5 |
Total Liabilities & Shareholders' Equity | 10.8 | 51.2 | 37.8 | 34.1 | 18.7 |
Total Common Shares Outstanding |